Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

598258

registered interest
date	10/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of recently published research from Breast Cancer Now on the availability of bisphosphonates.
tabling member constituency	Torfaen
tabling member printed	Nick Thomas-Symonds
uin	47612
answer	answer is ministerial correction date of answer 12/10/2016 answer text <p>The Independent Cancer Taskforce report included a specific recommendation on the use of adjuvant bisphosphonates for treating people with breast cancer. We understand that NHS England is working to realise the ambitions set out in the report and will publish an update on progress made soon.</p><p> </p><p>National prescribing arrangements already allow for bisphosphonates to be prescribed for the prevention of secondary breast cancer.</p><p> </p><p>Updated guidance from the National Institute for Health and Care Excellence on the use of adjuvant bisphosphonates for the management of breast cancer treatment-induced bone loss, taking into account the latest available evidence, is expected in July 2018.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 47140 47436 question first answered 12/10/2016 16:30:18 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4479 label Biography information for Nick Thomas-Symonds

598263

registered interest
date	10/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Doctors: Recruitment and Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department plans to take to recruit and train more doctors.
tabling member constituency	Mid Sussex
tabling member printed	Sir Nicholas Soames
uin	47663
answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>On 4 October 2016 my Rt. hon Friend the Secretary of State announced that the number of medical training places available to students each year will be expanded to ensure the National Health Service has enough doctors to continue to provide safe, compassionate care in the future. From September 2018, the Government will fund up to 1,500 additional student places through medical schools each year.</p><p>The ultimate responsibility for recruitment rests with NHS organisations as they are best placed to ensure they have the right staff, in the right place, at the right time to provide safe and effective care for their patients.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 13/10/2016 10:30:36 answering member 1542 label Biography information for Philip Dunne
tabling member	116 label Biography information for Lord Soames of Fletching

598273

registered interest
date	10/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Craniosynostosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effectiveness of NHS treatment of craniosynostosis; and if he will take steps to increase training and awareness of craniosynostosis amongst NHS professionals.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	47693
answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>The Department has made no assessment of the effectiveness of National Health Service treatment of craniosynostosis. All paediatricians are trained to recognise abnormality as part of general training up to Membership of the Royal College of Paediatrics and Child Health (MRCPCH) level.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 13/10/2016 10:31:34 answering member 1542 label Biography information for Philip Dunne
tabling member	4140 label Biography information for Mr David Nuttall

598276

registered interest
date	10/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services and Pharmacy: Productivity
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of relative levels of productivity in community pharmacy and secondary care in each year since 2005.
tabling member constituency	Dewsbury
tabling member printed	Paula Sherriff
uin	47790
answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>We have made no assessment of productivity in community pharmacies.</p> answering member constituency Warrington South answering member printed David Mowat grouped question UIN 47810 47884 question first answered 13/10/2016 13:07:31 answering member 4080 label Biography information for David Mowat
tabling member	4426 label Biography information for Paula Sherriff

598279

registered interest
date	10/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of changes to pharmacy funding on the availability of essential medicines.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	47751
answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>The Government’s proposals for community pharmacy in 2016/17 and beyond, on which we have consulted, are being considered against the public sector equality duty, the family test and the relevant duties of my Rt. hon. Friend, the Secretary of State for Health, under the National Health Service Act 2006.</p><p> </p><p>Our assessments include consideration of the potential impacts on the adequate provision of NHS pharmaceutical services, including the supply of medicines, access to NHS pharmaceutical services, supplementary hours, non-commissioned services, individuals with protected characteristics, impacts on other NHS services, health inequalities, individuals with restricted mobility and access to healthcare for deprived communities.</p><p> </p><p>An impact assessment will be completed to inform final decisions and published in due course.</p><p> </p><p>Our proposals are about improving services for patients and the public and securing efficiencies and savings. We believe these efficiencies can be made within community pharmacy without compromising the quality of services or public access to them.</p><p> </p><p>Our aim is to ensure that those community pharmacies upon which people depend continue to thrive. We are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared with others, considering factors such as location and the health needs of the local population.</p><p> </p><p>We want a clinically focussed community pharmacy service that is better integrated with primary care and public health in line with the Five Year Forward View. This will help relieve the pressure on general practitioners and accident and emergency departments, ensure better use of medicines and better patient outcomes, and contribute to delivering seven day health and care services.</p><p> </p><p>The Chief Pharmaceutical Officer for England, Dr Keith Ridge has commissioned an independent review of community pharmacy clinical services. The review is being led by Richard Murray, Director of Policy at The King’s Fund. The final recommendations will be considered as part of the development of clinical and cost effective patient care by pharmacists and their teams.</p><p> </p><p>NHS England is also setting up a Pharmacy Integration Fund to support the development of clinical pharmacy practice in a wider range of primary care settings, resulting in a more integrated and effective NHS primary care patient pathway.</p><p> </p><p>The rollout of the additional 1,500 clinical pharmacists announced by NHS England will help to ease current pressures in general practice by working with patients who have long term conditions and others with multiple medications. Having a pharmacist on site will mean that patients who receive care from their general practice will be able to benefit from the expertise in medicines that these pharmacists provide.</p> answering member constituency Warrington South answering member printed David Mowat grouped question UIN 47752 47761 47762 47806 47809 47871 47916 47920 47921 question first answered 13/10/2016 16:33:59 answering member 4080 label Biography information for David Mowat
tabling member	151 label Biography information for Tom Brake

598280

registered interest
date	10/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the potential effect of changes in pharmacy funding on waiting times for NHS prescriptions.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	47752
answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>The Government’s proposals for community pharmacy in 2016/17 and beyond, on which we have consulted, are being considered against the public sector equality duty, the family test and the relevant duties of my Rt. hon. Friend, the Secretary of State for Health, under the National Health Service Act 2006.</p><p> </p><p>Our assessments include consideration of the potential impacts on the adequate provision of NHS pharmaceutical services, including the supply of medicines, access to NHS pharmaceutical services, supplementary hours, non-commissioned services, individuals with protected characteristics, impacts on other NHS services, health inequalities, individuals with restricted mobility and access to healthcare for deprived communities.</p><p> </p><p>An impact assessment will be completed to inform final decisions and published in due course.</p><p> </p><p>Our proposals are about improving services for patients and the public and securing efficiencies and savings. We believe these efficiencies can be made within community pharmacy without compromising the quality of services or public access to them.</p><p> </p><p>Our aim is to ensure that those community pharmacies upon which people depend continue to thrive. We are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared with others, considering factors such as location and the health needs of the local population.</p><p> </p><p>We want a clinically focussed community pharmacy service that is better integrated with primary care and public health in line with the Five Year Forward View. This will help relieve the pressure on general practitioners and accident and emergency departments, ensure better use of medicines and better patient outcomes, and contribute to delivering seven day health and care services.</p><p> </p><p>The Chief Pharmaceutical Officer for England, Dr Keith Ridge has commissioned an independent review of community pharmacy clinical services. The review is being led by Richard Murray, Director of Policy at The King’s Fund. The final recommendations will be considered as part of the development of clinical and cost effective patient care by pharmacists and their teams.</p><p> </p><p>NHS England is also setting up a Pharmacy Integration Fund to support the development of clinical pharmacy practice in a wider range of primary care settings, resulting in a more integrated and effective NHS primary care patient pathway.</p><p> </p><p>The rollout of the additional 1,500 clinical pharmacists announced by NHS England will help to ease current pressures in general practice by working with patients who have long term conditions and others with multiple medications. Having a pharmacist on site will mean that patients who receive care from their general practice will be able to benefit from the expertise in medicines that these pharmacists provide.</p> answering member constituency Warrington South answering member printed David Mowat grouped question UIN 47751 47761 47762 47806 47809 47871 47916 47920 47921 question first answered 13/10/2016 16:33:59 answering member 4080 label Biography information for David Mowat
tabling member	151 label Biography information for Tom Brake

598281

registered interest
date	10/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Junior Doctors: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with the British Medical Association and the Royal Colleges on proposals to make junior doctors repay training costs if they leave the profession within five years.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	47804
answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>As announced by my Rt. hon Friend the Secretary of State on 4 October, the Government will run a public consultation in early 2017 on how medical graduates can provide a return on taxpayer investment through a minimum period service of four years in the National Health Service. All stakeholders will have an opportunity to input into policy development at this stage.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 13/10/2016 10:32:32 answering member 1542 label Biography information for Philip Dunne
tabling member	4418 label Biography information for Justin Madders

598282

registered interest
date	10/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of proposed reductions in pharmacy funding on specific patient populations.
tabling member constituency	South Thanet
tabling member printed	Craig Mackinlay
uin	47762
answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>The Government’s proposals for community pharmacy in 2016/17 and beyond, on which we have consulted, are being considered against the public sector equality duty, the family test and the relevant duties of my Rt. hon. Friend, the Secretary of State for Health, under the National Health Service Act 2006.</p><p> </p><p>Our assessments include consideration of the potential impacts on the adequate provision of NHS pharmaceutical services, including the supply of medicines, access to NHS pharmaceutical services, supplementary hours, non-commissioned services, individuals with protected characteristics, impacts on other NHS services, health inequalities, individuals with restricted mobility and access to healthcare for deprived communities.</p><p> </p><p>An impact assessment will be completed to inform final decisions and published in due course.</p><p> </p><p>Our proposals are about improving services for patients and the public and securing efficiencies and savings. We believe these efficiencies can be made within community pharmacy without compromising the quality of services or public access to them.</p><p> </p><p>Our aim is to ensure that those community pharmacies upon which people depend continue to thrive. We are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared with others, considering factors such as location and the health needs of the local population.</p><p> </p><p>We want a clinically focussed community pharmacy service that is better integrated with primary care and public health in line with the Five Year Forward View. This will help relieve the pressure on general practitioners and accident and emergency departments, ensure better use of medicines and better patient outcomes, and contribute to delivering seven day health and care services.</p><p> </p><p>The Chief Pharmaceutical Officer for England, Dr Keith Ridge has commissioned an independent review of community pharmacy clinical services. The review is being led by Richard Murray, Director of Policy at The King’s Fund. The final recommendations will be considered as part of the development of clinical and cost effective patient care by pharmacists and their teams.</p><p> </p><p>NHS England is also setting up a Pharmacy Integration Fund to support the development of clinical pharmacy practice in a wider range of primary care settings, resulting in a more integrated and effective NHS primary care patient pathway.</p><p> </p><p>The rollout of the additional 1,500 clinical pharmacists announced by NHS England will help to ease current pressures in general practice by working with patients who have long term conditions and others with multiple medications. Having a pharmacist on site will mean that patients who receive care from their general practice will be able to benefit from the expertise in medicines that these pharmacists provide.</p> answering member constituency Warrington South answering member printed David Mowat grouped question UIN 47751 47752 47761 47806 47809 47871 47916 47920 47921 question first answered 13/10/2016 16:34:00 answering member 4080 label Biography information for David Mowat
tabling member	4529 label Biography information for Craig Mackinlay

598284

registered interest
date	10/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Infant Foods: Advertising
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will issue a response to the report Scientific and factual? A review of breastmilk substitute advertising to healthcare professionals, published by the First Steps Nutrition Trust.
tabling member constituency	Glasgow Central
tabling member printed	Alison Thewliss
uin	47845
answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>My Rt. hon. Friend the Secretary of State has no plans to issue a response to the report, Scientific and Factual by First Steps Nutrition. The Infant Formula and Follow-on Formula (England) Regulations 2007 regulate the advertising of breast milk substitutes. These regulations are enforced by local authorities, who have been made aware of the report.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 13/10/2016 13:16:36 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4430 label Biography information for Alison Thewliss

598285

registered interest
date	10/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the likely effect of proposed changes to pharmacy funding on the provision of supplementary hours beyond the core NHS contract.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	47806
answer	answer is ministerial correction date of answer 13/10/2016 answer text <p>The Government’s proposals for community pharmacy in 2016/17 and beyond, on which we have consulted, are being considered against the public sector equality duty, the family test and the relevant duties of my Rt. hon. Friend, the Secretary of State for Health, under the National Health Service Act 2006.</p><p> </p><p>Our assessments include consideration of the potential impacts on the adequate provision of NHS pharmaceutical services, including the supply of medicines, access to NHS pharmaceutical services, supplementary hours, non-commissioned services, individuals with protected characteristics, impacts on other NHS services, health inequalities, individuals with restricted mobility and access to healthcare for deprived communities.</p><p> </p><p>An impact assessment will be completed to inform final decisions and published in due course.</p><p> </p><p>Our proposals are about improving services for patients and the public and securing efficiencies and savings. We believe these efficiencies can be made within community pharmacy without compromising the quality of services or public access to them.</p><p> </p><p>Our aim is to ensure that those community pharmacies upon which people depend continue to thrive. We are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared with others, considering factors such as location and the health needs of the local population.</p><p> </p><p>We want a clinically focussed community pharmacy service that is better integrated with primary care and public health in line with the Five Year Forward View. This will help relieve the pressure on general practitioners and accident and emergency departments, ensure better use of medicines and better patient outcomes, and contribute to delivering seven day health and care services.</p><p> </p><p>The Chief Pharmaceutical Officer for England, Dr Keith Ridge has commissioned an independent review of community pharmacy clinical services. The review is being led by Richard Murray, Director of Policy at The King’s Fund. The final recommendations will be considered as part of the development of clinical and cost effective patient care by pharmacists and their teams.</p><p> </p><p>NHS England is also setting up a Pharmacy Integration Fund to support the development of clinical pharmacy practice in a wider range of primary care settings, resulting in a more integrated and effective NHS primary care patient pathway.</p><p> </p><p>The rollout of the additional 1,500 clinical pharmacists announced by NHS England will help to ease current pressures in general practice by working with patients who have long term conditions and others with multiple medications. Having a pharmacist on site will mean that patients who receive care from their general practice will be able to benefit from the expertise in medicines that these pharmacists provide.</p> answering member constituency Warrington South answering member printed David Mowat grouped question UIN 47751 47752 47761 47762 47809 47871 47916 47920 47921 question first answered 13/10/2016 16:33:59 answering member 4080 label Biography information for David Mowat
tabling member	4418 label Biography information for Justin Madders